Cardiac ablation and mapping
Clinical evidence
Explore clinical studies and evidence that evaluate our novel cardiac ablation technologies.
SPHERE Per-AF was a randomized trial of persistent AF patients comparing the Sphere-9™ catheter with the Affera™ mapping and ablation system to the Thermocool STSF™* SMARTTOUCH®* SF catheter with the CARTO®* 3 system.
PULSED AF evaluated the safety and effectiveness of the PulseSelect™ pulsed field ablation (PFA) system for the treatment of patients with paroxysmal (PAF) or persistent (PsAF) atrial fibrillation.
View data from the clinical trial assessing initial rhythm control of paroxysmal AF with cryoballoon ablation versus antiarrhythmic drugs.
View information on this clinical trial assessing the safety and efficacy of the Medtronic cryoballoon in treating persistent AF patients.
This trial assessed the use of the Freezor™ Xtra cardiac cryoablation catheter in treating AVNRT.
Learn more about this randomized study on the effectiveness of the Arctic Front™ and Arctic Front Advance™ cardiac cryoablation catheters.
Discover information on this 1:1 randomized, noninferiority study comparing cryoballoon and radiofrequency ablation.
®* and TM* Third-party brands are trademarks of their respective owners.
We do not review or control the content of external sites and are not responsible for any interactions or transactions that may occur there. Any product availability and regulatory requirements on the destination site may differ depending on your location. When you continue, the terms of use and privacy statement of the external site will apply.
Product availability and regulatory requirements may differ depending on your location. The destination website is governed by the laws and regulations of the country in which it operates, which may be different from those in your country. When you continue, the terms of use and privacy statement of the destination Medtronic site will apply.